ParshallMBSchwartzsteinRMAdamsL. American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med2012; 185: 435–452.
2.
AbidovARozanskiAHachamovitchR. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med2005; 353: 1889–1898.
3.
SantosMKitzmanDWMatsushitaK. Prognostic importance of dyspnea for cardiovascular outcomes and mortality in persons without prevalent cardiopulmonary disease: The atherosclerosis risk in communities study. PloS One2016; 11: e0165111–e0165111.
4.
Biering-SorensenTSantosMRiveroJ. Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea. Eur J Heart Fail2017; 19: 101–110.
5.
BernhardtVBabbTG. Exertional dyspnoea in obesity. Eur Respir Rev2016; 25: 487–495.
6.
DePasoWJWinterbauerRHLuskJA. Chronic dyspnea unexplained by history, physical examination, chest roentgenogram, and spirometry. Analysis of a seven-year experience. Chest1991; 100: 1293–1299.
7.
GuazziMBorlaugBA. Pulmonary hypertension due to left heart disease. Circulation2012; 126: 975–990.
GuazziMArenaRHalleM. 2016 Focused update: Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation2016; 133: e694–e711.
10.
OliveiraRKWaxmanABAgarwalM. Pulmonary haemodynamics during recovery from maximum incremental cycling exercise. Eur Respir J2016; 48: 158–167.
ObokataMReddyYNPislaruSV. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation2017. DOI: 10.1161/CIRCULATIONAHA.116.026807.
13.
HuangWRSOliveiraRKFCockrillBA. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center. Eur J Prev Cardiol2017. DOI: 10.1177/2047487317709605.
14.
WolskEBakkestromRThomsenJH. The influence of age on hemodynamic parameters during rest and exercise in healthy individuals. JACC Heart Fail2017; 5: 337–346.
15.
GalieNHumbertMVachieryJL. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society Of Cardiology (esc) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J2016; 37: 67–119.
16.
GuazziM. Stress echocardiography combined with cardiopulmonary exercise testing: Opening a new window into diagnosis of heart failure with preserved ejection fraction. Eur J Prev Cardiol2016; 23: 67–70.
17.
ShimiaieJSherezJAviramG. Determinants of effort intolerance in patients with heart failure: Combined echocardiography and cardiopulmonary stress protocol. JACC Heart Fail2015; 3: 803–814.
18.
BanderaFGeneratiGPellegrinoM. Mitral regurgitation in heart failure: Insights from CPET combined with exercise echocardiography. Eur Heart J Cardiovasc Imaging2017; 18: 296–303.